Inclusion of lidocaine in cardioplegic solutions provides additional myocardial protection

Journal of Cardiovascular Surgery

Volumn 45, Issue 6, 2004, Pages 551-555

  Dias, R R ^a,b   Stolf, N A G ^a   Dalva, M ^a   Dias, A R ^a   Moreira, L F P ^a   Oliveira, S A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Div Cirúrgica São Paulo   (Brazil)

Author keywords

Cardioplegic solution; Lidocaine; Myocardial protection

Indexed keywords

LIDOCAINE; POTASSIUM CHLORIDE; TROPONIN I; ANTIARRHYTHMIC AGENT; CARDIOPLEGIC AGENT; CREATINE KINASE; LACTIC ACID;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; DRUG EFFICACY; ENZYME RELEASE; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HEART PROTECTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; STATISTICAL ANALYSIS; SURVIVAL RATE; ANIMAL; BLOOD; DRUG COMBINATION; HEART STROKE VOLUME; HEART SURGERY; RANDOMIZATION; TIME;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIAC SURGICAL PROCEDURES; CARDIOPLEGIC SOLUTIONS; CREATINE KINASE; DOGS; DRUG THERAPY, COMBINATION; LACTIC ACID; LIDOCAINE; MYOCARDIAL ISCHEMIA; POTASSIUM CHLORIDE; RANDOM ALLOCATION; STROKE VOLUME; TIME FACTORS; TROPONIN I;

EID: 15744379229     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bigger JR, Hoffman BF. Drogas anti-arrítmicas. In: Goodman & Gilman A. Rall TW, Nies AS, Taylor P, editors. As bases farmacológicas da terapêutica. Rio de Janeiro: Guanabara Koogan, 1991;35.p.553-74.
2. Bengtsson L, Gunnes S, Norman B, Karlsson J. The effect of lidocaine on myocardial ischemia with asanguinous reperfusion. Scand J Thor Cardiovasc Surg 1991;25:141-6.
3. Demmy TL, Haggerty SP, Boley TM, Curtis JJ. Lack of cardioplegia uniformity in clinical myocardial preservation. Ann Thorac Surg 1994;57:649-51-
4. McGooon DC. The ongoing quest for ideal myocardial protection. A catalog of the recent English literature. J Thorac Cardiovasc Surg 1985;89:639-53.
5. Cordell AR. Milestones in the development of cardioplegia. Ann Thorac Surg 1995;60:793-6.
6. rd edition. Rio de Janeiro: Interamericana, 1983.p.1-37.
7. Jennings RB, Reimer KA. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood. Circulation 1983:68 Suppl 1:25-36.
8. Ferrari R. Metabolic disturbances during myocardial ischemia and reperfusion. Am J Cardiol 1995;76:17-24.
9. Waxman K. Shock: ischemia, reperfusion, and inflammation. New Horiz 1996;4:153-60.
10. Hammond B, Hess ML. The oxygen free radical system: potential mediator of myocardial injury. J Am Coll Cardiol 1985;6:215-20.
11. Buckberg GD. Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg 1987;93:127-39.
12. Buckberg GD. A proposed solution to the cardioplegic controversy. J Thorac Cardiovasc Surg 1979;77:803-15.
13. Sunamori M, Amano J, Okamura T, Suma H, Suzuki A. Superior action of magnesium-lidocaine-L-aspartate cardioplegia to glucose-insuline-potassium cardioplegia in experimental myocardial protection. Jpn J Surg 1982;12:372-80.
14. Kyo S, Laraia PJ, Magrassi P, Levine FH, Tsai C, Austen G et al. Myocardial protection by lidocaine during cardioplegia. J Surg Res 1983;34:533-42.
15. Fiore AC, Naunheim KS, Taub J, Braun P, McBride LR, Pennington G et al. Myocardial preservation using lidocaine blood cardioplegia. Ann Thorac Surg 1990;50:771-5.
16. Okamura T, Sunamori M, Suzuki A. Protective effect of lidocaine in reperfused ischemic myocardium. Evaluation by hemodynamic and biochemical study. Jpn Circulation J 1982;46:657-62.
17. Nasser FN, Walls JT, Edwards WD, Harrison CE Jr, Dewey JD. Lidocaine-induced reduction in size of experimental myocardial infarction. Am J Cardiol 1980;46:967-75.
18. Lee R, Nitta T, Schmid RA, Schuessler RB, Harris KM, Gay WA Jr et al. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size. Ann Thorac Surg 1998;65:1353-9.
19. Lesnefsky EJ, Vanbenthuysen KM, Mcmurtry IF, Shikes RH, Johnston RB Jr, Horwitz LD. Lidocaine reduces canine infarct size and decreases release of a lipid peroxidation product. J Cardiovasc Pharmacol 1989;13:895-901.
20. Sunamori M, Okamura T, Amano J, Suma H, Suzuki A. Myocardial protection by lidocaine hydrochloride in aorto-coronary bypass surgery. Jpn J Surg 1982;12:93-7.
21. Rinne T, Kaukinen S. Does lidocaine protect the heart during coronary revascularization? Acta Anaesthesiol Scand 1998;42:936-40.
22. Carrier M, Tourigny A, Thoribé N, Montpetit M, Khalil A, Solymoss C et al. Effects of cold and warm blood cardioplegia assessed by myocardial pH and release of metabolic markers. Ann Thorac Surg 1994;58:764-7.
23. Jennings RB, Reimer KA. Lethal myocardial ischemic injury. Am J Pathol 1981;102:241-55.
24. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988;96:379-94.
25. Junqueira LC, Carneiro J. The cell. In: Junqueira LC, Carneiro J, editors. Basic histology. 4th edition. Rio de Janeiro: Guanabara Koogan SA; 1985.p.31-55.